Treatment of multiple sclerosis
- 29 January 1994
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 343 (8892), 275-279
- https://doi.org/10.1016/s0140-6736(94)91119-3
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The pathological evolution of multiple sclerosisNeuropathology and Applied Neurobiology, 1992
- THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDYBrain, 1991
- The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosisThe Lancet, 1991
- Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six monthsAnnals of Neurology, 1989
- Randomised double blind controlled trial of cyclosporin in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisNew England Journal of Medicine, 1987
- Intravenous methylprednisolone for multiple sclerosis in relapse.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Intensive Immunosuppression in Progressive Multiple SclerosisNew England Journal of Medicine, 1983
- Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activityNature, 1974